TD139, A Novel Inhaled Galectin-3 Inhibitor for The Treatment of Idiopathic Pulmonary Fibrosis (IPF). Results from The First in (IPF) Patients Study.
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.